NDC 70771-1087-2 - oxybutynin
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 70771-1087
- Requested NDC
- 70771-1087-2
- Package NDCs from labels
- 70771-1087-6, 70771-1087-1, 70771-1087-9, 70771-1087-5, 70771-1087-3, 70771-1087-2, 70771-1087-4
- Manufacturer
- Zydus Lifesciences Limited
- Effective date
- 2024-12-03
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| oxybutynin - Zydus Lifesciences Limited | Zydus Lifesciences Limited | 2024-12-03 | HUMAN PRESCRIPTION DRUG LABEL |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 70771-1087-1 | oxybutynin | 100 in 1 BOTTLE | TABLET, FILM COATED, EXTENDED RE | 100 | 8 | |
| 70771-1087-2 | oxybutynin | 10 in 1 BLISTER PACK | TABLET, FILM COATED, EXTENDED RE | 10 | 8 | |
| 70771-1087-3 | oxybutynin | 30 in 1 BOTTLE | TABLET, FILM COATED, EXTENDED RE | 30 | 8 | |
| 70771-1087-4 | oxybutynin | 10 in 1 CARTON | TABLET, FILM COATED, EXTENDED RE | 10 | 8 | |
| 70771-1087-5 | oxybutynin | 500 in 1 BOTTLE | TABLET, FILM COATED, EXTENDED RE | 500 | 8 | |
| 70771-1087-6 | oxybutynin | 60 in 1 BOTTLE | TABLET, FILM COATED, EXTENDED RE | 60 | 8 | |
| 70771-1087-9 | oxybutynin | 90 in 1 BOTTLE | TABLET, FILM COATED, EXTENDED RE | 90 | 8 |
DailyMed Dashboard NDC Coverage#
| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|---|---|---|---|
| 70771-1087 | OXYBUTYNIN TABLET, FILM COATED, EXTENDED RELEASE [ZYDUS LIFESCIENCES LIMITED] | 8 | Current NDC, Legacy NDC, 7 package rows | 20241206_f405a774-bd91-4513-b7c7-c44f0596d988.zip |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Oxybutynin Chloride Extended Release | OXYBUTYNIN CHLORIDE | AvKARE | 94471401-a516-0fe7-ec9c-447dd2bee972 | 2025-12-16 | Warnings, Adverse reactions | 863636 863619 863628 L9F3D9RENQ |
| Artificial Tears | GLYCERIN | NuCare Pharmaceuticals,Inc. | 97a3d8e2-b2c0-3f5d-e053-2a95a90ac49d | 2025-12-15 | Warnings | 3NXW29V3WO |
| Oxybutynin Chloride | OXYBUTYNIN CHLORIDE | Upsher-Smith Laboratories, LLC | 3ee6835a-7a7d-49a9-8460-2f1dd270ead3 | 2025-12-11 | Warnings, Adverse reactions | L9F3D9RENQ |
| Oxybutynin Chloride | OXYBUTYNIN CHLORIDE | Ajanta Pharma USA Inc. | 95c2a144-ba0d-4011-ae0f-0e0ca876e8a8 | 2025-11-30 | Warnings, Adverse reactions | 863636 863619 863628 L9F3D9RENQ |
| OUHOE Biotin With Hydrolyzed Collagen | GLYCERIN | Shantou Ouhoe Technology Co., Ltd. | 43138915-5fe1-6e32-e063-6294a90abefa | 2025-11-27 | Warnings | ZF94AP8MEY |
| HOUKEA Pure Magnesium Oil | GLYCERIN | Guangzhou Houkea Biotechnology Co., Ltd. | 33fc279b-3b15-973d-e063-6394a90aad3e | 2025-11-27 | Warnings | ZF94AP8MEY |
| OXYBUTYNIN CHLORIDE | OXYBUTYNIN CHLORIDE | A-S Medication Solutions | 44990ed6-b8e7-40f5-b636-e848024ec6d8 | 2025-11-18 | Warnings, Adverse reactions | L9F3D9RENQ |
| OXYBUTYNIN CHLORIDE | OXYBUTYNIN CHLORIDE | A-S Medication Solutions | 0697b3cf-b146-47c0-b5a5-5905ae8d1c97 | 2025-11-18 | Warnings, Adverse reactions | L9F3D9RENQ |
| Oxybutynin Chloride | OXYBUTYNIN CHLORIDE | VERITYRX, LLC | 427b6ffb-3ff4-932f-e063-6394a90ae8b9 | 2025-10-31 | Warnings, Adverse reactions | L9F3D9RENQ |
| LACRIFRESH HYDRAPF | GLYCERIN, POVIDONE | AVIZOR, S.A. | 41bbd23e-0ec8-eb18-e063-6294a90a46d1 | 2025-10-27 | Warnings | FZ989GH94E |
| LACRIFRESH HYDRAMAXPF | GLYCERIN, POVIDONE | AVIZOR, S.A. | 41be1604-89b4-7ec3-e063-6294a90a3331 | 2025-10-27 | Warnings | FZ989GH94E |
| Stye | POLYVINYL ALCOHOL AND POVIDONE | Medtech Products Inc. | 60c11d3d-df20-4d1c-b425-49a84fecea30 | 2025-10-23 | Warnings | FZ989GH94E |
| Wasted | BENZALKONIUM CHLORIDE | Freshorize Ltd | 0c43b516-7608-c826-e063-6294a90ae4e3 | 2025-10-23 | Warnings | ZF94AP8MEY |
| iVIZIA Dry Eye | POVIDONE | Thea Pharma Inc. | 1ef73cb1-da48-a713-e063-6294a90afa9d | 2025-10-20 | Warnings | FZ989GH94E |
| Oxybutynin Chloride Extended Release | OXYBUTYNIN CHLORIDE | PD-Rx Pharmaceuticals, Inc. | b5653b7e-1e3b-4da3-b3a2-33318f448c67 | 2025-10-20 | Warnings, Adverse reactions | 863619 L9F3D9RENQ |
| Oxybutynin Chloride Extended Release | OXYBUTYNIN CHLORIDE | PD-Rx Pharmaceuticals, Inc. | e466d963-469a-4b1c-87f9-2e3e1e9bdf3d | 2025-10-02 | Warnings, Adverse reactions | 863619 L9F3D9RENQ |
| Oxybutynin Chloride | OXYBUTYNIN CHLORIDE | Major Pharmaceuticals | 7769ad3d-6228-4b2d-8f44-4efe990d3fad | 2025-09-19 | Warnings, Adverse reactions | L9F3D9RENQ |
| Eyes Irritation Relief | POLYVINYL ALCOHOL AND POVIDONE AND TETRAHYDROZOLINE HYDROCHLORIDE | CARDINAL HEALTH 110, LLC. DBA LEADER | bd2608c6-ffdf-352a-e053-2995a90a26a8 | 2025-09-12 | Warnings | FZ989GH94E |
| Oxybutynin Chloride | OXYBUTYNIN CHLORIDE | Cardinal Health 107, LLC | 8455b543-81ce-4522-ae9b-8396f944945c | 2025-08-18 | Warnings, Adverse reactions | L9F3D9RENQ |
| OXYBUTYNIN CHLORIDE | OXYBUTYNIN CHLORIDE | PD-Rx Pharmaceuticals, Inc. | 8bd5dce0-d56a-4e64-8de7-e7cd7775526b | 2025-08-18 | Warnings, Adverse reactions | L9F3D9RENQ |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.